Genetic variants are major determinants of CSF antibody levels in multiple sclerosis

Brain

Volumn 138, Issue 3, 2015, Pages 632-643

  Goris, An ^a   Pauwels, Ine ^a   Gustavsen, Marte W ^b,c   Van Son, Brechtje ^d   Hilven, Kelly ^a   Bos, Steffan D ^b,c   Celius, Elisabeth Gulowsen ^b   Berg Hansen, Pal ^b,c   Aarseth, Jan ^e   Myhr, Kjell Morten ^e,f   D'Alfonso, Sandra ^g   Barizzone, Nadia ^g   Leone, Maurizio A ^g,h   Boneschi, Filippo Martinelli ⁱ   Sorosina, Melissa ⁱ   Liberatore, Giuseppe ⁱ   Kockum, Ingrid ^j   Olsson, Tomas ^j   Hillert, Jan ^j   Alfredsson, Lars ^j   Bedri, Sahl Khalid ^j   Hemmer, Bernhard ^k,l   Buck, Dorothea ^k   Berthele, Achim ^k   Knier, Benjamin ^k   Biberacher, Viola ^k   Van Pesch, Vincent ^m   Sindi, Christian ^m   Oturai, Annette Bang ⁿ   Søndergaard, Helle Bach ⁿ   Sellebjerg, Finn ⁿ   Jensen, Poul Erik H ⁿ   Comabella, Manuel ^o   Montalban, Xavier ^o   Pérez Boza, Jennifer ^o   Malhotra, Sunny ^o   Lechner Scott, Jeannette ^p   Broadley, Simon ^q   Slee, Mark ^r   Taylor, Bruce ^s   Kermode, Allan G ^t,u   Gourraud, Pierre Antoine ^v   Sawcer, Stephen J ^w   Andreassen, Bettina Kullle ^c   Dubois, Bénédicte ^a,d   Harbo, Hanne F ^b,c   more..

^a KU LEUVEN UNIVERSITY OF LEUVEN   (Belgium)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF BERGEN   (Norway)

^g UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^h CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

ⁱ SAN RAFFAELE HOSPITAL   (Italy)

^j KAROLINSKA INSTITUTE   (Sweden)

^k TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^l Technische Universität München Munich Cluster for Systems Neurology   (Germany)

^m UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

ⁿ Rigshospitalet   (Denmark)

^o HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^p UNIVERSITY OF NEWCASTLE   (Australia)

^q GRIFFITH UNIVERSITY   (Australia)

^r FLINDERS UNIVERSITY   (Australia)

^s UNIVERSITY OF TASMANIA   (Australia)

^t MURDOCH UNIVERSITY   (Australia)

^u UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^v UNIVERSITY OF CALIFORNIA   (United States)

^w UNIVERSITY OF CAMBRIDGE   (United Kingdom)

more..

Author keywords

CSF; Genetics; Immunoglobulin; Multiple sclerosis; Oligoclonal bands

Indexed keywords

HLA DQA1 ANTIGEN; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; OLIGOCLONAL BAND; ELAC1 PROTEIN, HUMAN; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; DISEASE SEVERITY; FEMALE; GENE; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC VARIABILITY; HAPLOTYPE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; AGED; BLOOD; CEREBROSPINAL FLUID; CHILD; EUROPE; GENETICS; MIDDLE AGED; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EUROPE; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HUMANS; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; SMAD4 PROTEIN; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84930571293     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awu405     Document Type: Article

References (51)

1. Allanore Y, Saad M, Dieude P, Avouac J, Distler JH, Amouyel P, et al. Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. PLoS Genet 2011; 7: e1002091.
2. Berg-Hansen P, Smestad C, Sandvik L, Harbo HF, Celius EG. Increased disease severity in non-Western immigrants with multiple sclerosis in Oslo, Norway. Eur J Neurol 2013; 20: 1546-52.
3. Buck D, Albrecht E, Aslam M, Goris A, Hauenstein N, Jochim A, et al. Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis. Ann Neurol 2012; 73: 86-94.
4. Cepok S, Jacobsen M, Schock S, Omer B, Jaekel S, Boddeker I, et al. Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain 2001; 124 (Pt 11): 2169-76.
5. Cepok S, Rosche B, Grummel V, Vogel F, Zhou D, Sayn J, et al. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 2005; 128 (Pt 7): 1667-76.
6. Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372: 1502-17.
7. Dilthey AT, Moutsianas L, Leslie S, McVean G. HLA∗IMP-an integrated framework for imputing classical HLA alleles from SNP genotypes. Bioinformatics 2011; 27: 968-72.
8. Dobson R, Ramagopalan S, Davis A, Giovannoni G. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry 2013; 84: 909-14.
9. Ferreira RC, Pan-Hammarstrom Q, Graham RR, Gateva V, Fontan G, Lee AT, et al. Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat Genet 2010; 42: 777-80.
10. Fukazawa T, Kikuchi S, Sasaki H, Hamada K, Hamada T, Miyasaka K, et al. The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds. J Neurol Sci 1998; 158: 209-14.
11. Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, et al. In primary Sjogren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Arthritis Rheum 2003; 48: 2240-5.
12. Gourraud PA, McElroy JP, Caillier SJ, Johnson BA, Santaniello A, Hauser SL, et al. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Ann Neurol 2011; 69: 65-74.
13. Haghighi S, Andersen O, Rosengren L, Bergstrom T, Wahlstrom J, Nilsson S. Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls. J Neurol 2000; 247: 616-22.
14. Harbo HF, Isobe N, Berg-Hansen P, Bos SD, Caillier SJ, Gustavsen MW, et al. Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis. Mult Scler 2014; 20: 660-8.
15. Hensiek AE, Sawcer SJ, Feakes R, Deans J, Mander A, Akesson E, et al. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry 2002; 72: 184-7.
16. Huss DJ, Winger RC, Cox GM, Guerau-de-Arellano M, Yang Y, Racke MK, et al. TGF-beta signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE. Eur J Immunol 2011; 41: 2987-96.
17. Idiman E, Ozakbas S, Dogan Y, Kosehasanogullari G. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds. J Neuroimmunol 2009; 212: 121-4.
18. Imrell K, Landtblom AM, Hillert J, Masterman T. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immu-nogenetically distinct. Neurology 2006; 67: 1062-4.
19. Ishii M, Hasegawa G, Fukui M, Obayashi H, Ohta M, Ogata M, et al. Clinical and genetic characteristics of diabetic patients with high-titer (410, 000 U/ml) of antibodies to glutamic acid decarb-oxylase. Immunol Lett 2005; 99: 180-5.
20. Jersild C, Svejgaard A, Fog T. HL-A antigens and multiple sclerosis. Lancet 1972; 1: 1240-1.
21. Kikuchi S, Fukazawa T, Niino M, Yabe I, Miyagishi R, Hamada T, et al. HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. Human leukocyte antigen. Neurology 2003; 60: 647-51.
22. Lechner-Scott J, Spencer B, de Malmanche T, Attia J, Fitzgerald M, Trojano M, et al. The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude. Mult Scler 2011; 18: 974-82.
23. Leone MA, Barizzone N, Esposito F, Lucenti A, Harbo HF, Goris A, et al. Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients. PLoS One 2013; 8: e64408.
24. Link H, Huang YM. Oligoclonal bands in multiple sclerosis cerebro-spinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 2006; 180: 17-28.
25. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007; 130 (Pt 4): 1089-104.
26. Mayringer I, Timeltaler B, Deisenhammer F. Correlation between the IgG index, oligoclonal bands in CSF, and the diagnosis of demyeli-nating diseases. Eur J Neurol 2005; 12: 527-30.
27. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-7.
28. Meoli EM, Oh U, Grant CW, Jacobson S. TGF-beta signaling is altered in the peripheral blood of subjects with multiple sclerosis. J Neuroimmunol 2010; 230: 164-8.
29. Mero IL, Gustavsen MW, Saether HS, Flam ST, Berg-Hansen P, Sondergaard HB, et al. Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk al-leles. PLoS One 2013; 8: e58352.
30. Oak S, Gaur LK, Radtke J, Patel R, Iyer D, Ram N, et al. "Masked" and overt autoantibodies specific to the DPD epitope of 65 kDa glutamate decarboxylase (GAD65-DPD) are associated with preserved beta cell functional reserve in Ketosis-Prone Diabetes. J Clin Endocrinol Metab 2014; 99: E1040-4.
31. Orozco G, Viatte S, Bowes J, Martin P, Wilson AG, Morgan AW, et al. Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome-wide association study. Arthritis Rheumatol 2014; 66: 24-30.
32. Ovsyannikova IG, Kennedy RB, O'Byrne M, Jacobson RM, Pankratz VS, Poland GA. Genome-wide association study of antibody response to smallpox vaccine. Vaccine 2012; 30: 4182-9.
33. Pandey JP. Immunoglobulin GM allotypes in multiple sclerosis. Ann Neurol 2013; 73: 148.
34. Park SR, Seo GY, Choi AJ, Stavnezer J, Kim PH. Analysis of transforming growth factor-beta1-induced Ig germ-line gamma2b transcription and its implication for IgA isotype switching. Eur J Immunol 2005; 35: 946-56.
35. Plagnol V, Howson JM, Smyth DJ, Walker N, Hafler JP, Wallace C, et al. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet 2011; 7: e1002216.
36. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
37. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-75.
38. Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, et al. Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 2010; 42: 426-9.
39. Rinker JR, Trinkaus K II, Naismith RT, Cross AH. Higher IgG index found in African Americans versus Caucasians with multiple sclerosis. Neurology 2007; 69: 68-72.
40. Romero-Pinel L, Martinez-Yelamos S, Bau L, Matas E, Gubieras L, Maria Pujal J, et al. Association of HLA-DRB1∗15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort. Eur J Neurol 2011; 18: 1258-62.
41. Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, et al. Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 2005; 64: 1144-51.
42. Rubicz R, Yolken R, Drigalenko E, Carless MA, Dyer TD, Bauman L, et al. A Genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1). PLoS Genet 2013; 9: e1003147.
43. Rudick RA, Cookfair DL, Simonian NA, Ransohoff RM, Richert JR, Jacobs LD, et al. Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The multiple sclerosis collaborative research group. J Neuroimmunol 1999; 93: 8-14.
44. Stangel M, Fredrikson S, Meinl E, Petzold A, Stuve O, Tumani H. The utility of cerebrospinal fluid analysis in patients with multiple sclerosis. Nat Rev Neurol 2013; 9: 267-76.
45. Sundqvist E, Buck D, Warnke C, Albrecht E, Gieger C, Khademi M, et al. JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants. PLoS Pathog 2014; 10: e1004084.
46. The International MHC and Autoimmunity Genetics Network. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. Proc Natl Acad Sci USA 2009; 106: 18680-5.
47. The International Multiple Sclerosis Genetics Consortium. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013; 45: 1353-60.
48. The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-9.
49. Tintore M, Rovira A, Rio J, Tur C, Pelayo R, Nos C, et al. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 2008; 70 (13 Pt 2): 1079-83.
50. Wu JS, Qiu W, Castley A, James I, Joseph J, Christiansen FT, et al. Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort. J Neurol Sci 2009; 288: 63-7.
51. Yoshimura S, Isobe N, Matsushita T, Masaki K, Sato S, Kawano Y, et al. Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients. PLoS One 2014; 9: e95367.